phd in cancer research in canada

• Doctor of Philosophy in Interdisciplinary Oncology (PhD)
• Graduate School
• Prospective Students
• Graduate Degree Programs

Canadian Immigration Updates

Applicants to Master’s and Doctoral degrees are not affected by the recently announced cap on study permits. Review more details

Go to programs search

The Interdisciplinary Oncology program (IOP) is a graduate program designed to appeal to a broad range of students interested in cancer research. IOP offers advanced study and research in a variety of fields relating to oncology. Those fields include: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, molecular pathology, sociobehavioral studies, epidemiology and health economics. The goal of the program is to provide graduate students from diverse backgrounds, with an education in a number of disciplines relating to oncology, and to provide training opportunities for intensive training in specialized aspects of cancer research. For more than ten years, the program has been training the next generation of cancer research leaders.

For specific program requirements, please refer to the departmental program website

What makes the program unique?

IOP integrates the diverse areas of oncology by offering two required courses which provide an interdisciplinary perspective on oncology in a form that is accessible to students from diverse backgrounds. The elective courses provide intensive training in one or more subjects specific to the student's research, and also gives the student an opportunity to gain expertise in other disciplines that have potential for synergy with their primary specialization. Students have access to clinicians and university faculty through the world-renowned BC Cancer Agency, to get a practical perspective on oncology treatments and outcomes. An innovative rotation course is a unique option for students to gain hands-on experience by rotating through specialty laboratories and by shadowing clinicians. 

The Interdisciplinary Oncology Program (IOP) attracted me primarily because of its interdisciplinary aspect, as I believed it would allow me to learn about various facets of cancer biology simultaneously. This is important in my mind because graduate students inevitably become experts on niche subjects and often miss important connections between their research focus and other disciplines.

Louis-Alexandre Fournier

Quick Facts

Program enquiries, admission information & requirements, program instructions.

Students must secure a supervisor before they can be admitted into the program. As well, they must meet the minimum admission requirements set out by Graduate and Post-doctoral Studies at UBC.

1) Check Eligibility

Minimum academic requirements.

The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:

• Canada or the United States
• International countries other than the United States

Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.

English Language Test

Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.

Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:

TOEFL: Test of English as a Foreign Language - internet-based

Overall score requirement : 100

IELTS: International English Language Testing System

Overall score requirement : 7.0

Other Test Scores

Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:

The GRE is not required.

Prior degree, course and other requirements

Prior degree requirements.

A B.Sc is the minimum requirement.

Document Requirements

CV, Official transcripts, three letters of reference, Official English exam scores (if required)

2) Meet Deadlines

September 2024 intake, application open date, canadian applicants, international applicants, january 2025 intake, may 2025 intake, september 2025 intake, deadline explanations.

Deadline to submit online application. No changes can be made to the application after submission.

Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.

Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.

3) Prepare Application

Transcripts.

All applicants have to submit transcripts from all past post-secondary study. Document submission requirements depend on whether your institution of study is within Canada or outside of Canada.

Letters of Reference

A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.

Statement of Interest

Many programs require a statement of interest , sometimes called a "statement of intent", "description of research interests" or something similar.

Supervision

Students in research-based programs usually require a faculty member to function as their thesis supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.

Instructions regarding thesis supervisor contact for Doctor of Philosophy in Interdisciplinary Oncology (PhD)

Citizenship verification.

Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.

4) Apply Online

All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.

Research Information

Program components.

Once students are enrolled in the program, they will have an opportunity to design a program that allows for rotations through other IOP faculty's labs to gain insight into other research areas other than their specific supervisor's research.

Research Facilities

Most IOP supervisors reside off-campus at the BC Cancer Research Centre, the Prostate Centre at Vancouver General Hospital or other hospital-related buildings.

Tuition & Financial Support

Financial support.

Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.

Program Funding Packages

All students who secure a supervisor and who are enrolled in the program will be paid a minimum stipend of $24,300/year.

Average Funding

• 8 students received Teaching Assistantships. Average TA funding based on 8 students was $6,093.
• 17 students received Research Assistantships. Average RA funding based on 17 students was $23,759.
• 3 students received Academic Assistantships. Average AA funding based on 3 students was $2,530.
• 36 students received internal awards. Average internal award funding based on 36 students was $8,795.
• 5 students received external awards. Average external award funding based on 5 students was $27,333.

Scholarships & awards (merit-based funding)

All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.

Graduate Research Assistantships (GRA)

Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their supervision. The duties constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is considered a form of fellowship for a period of graduate study and is therefore not covered by a collective agreement. Stipends vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded.

Graduate Teaching Assistantships (GTA)

Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union .

Graduate Academic Assistantships (GAA)

Academic Assistantships are employment opportunities to perform work that is relevant to the university or to an individual faculty member, but not to support the student’s graduate research and thesis. Wages are considered regular earnings and when paid monthly, include vacation pay.

Financial aid (need-based funding)

Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans .

All students may be able to access private sector or bank loans.

Foreign government scholarships

Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.

Working while studying

The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.

International students enrolled as full-time students with a valid study permit can work on campus for unlimited hours and work off-campus for no more than 20 hours a week.

A good starting point to explore student jobs is the UBC Work Learn program or a Co-Op placement .

Tax credits and RRSP withdrawals

Students with taxable income in Canada may be able to claim federal or provincial tax credits.

Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.

Please review Filing taxes in Canada on the student services website for more information.

Cost Estimator

Applicants have access to the cost estimator to develop a financial plan that takes into account various income sources and expenses.

Career Outcomes

7 students graduated between 2005 and 2013: 1 is in a non-salaried situation; for 0 we have no data (based on research conducted between Feb-May 2016). For the remaining 6 graduates:

Sample Employers in Higher Education

Sample employers outside higher education, sample job titles outside higher education, phd career outcome survey, career options.

Graduates have a wide range of options from working in government institutions to academia to biotechnology and bio-pharm companies. Those looking to further their academic career have are undertaking post-doctoral positions in Canada and abroad.

Enrolment, Duration & Other Stats

These statistics show data for the Doctor of Philosophy in Interdisciplinary Oncology (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.

ENROLMENT DATA

Completion rates & times, upcoming doctoral exams, monday, 24 june 2024 - 2:00pm.

• Research Supervisors

Advice and insights from UBC Faculty on reaching out to supervisors

These videos contain some general advice from faculty across UBC on finding and reaching out to a supervisor. They are not program specific.

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

• Aparicio, Samuel (Breast cancer, genome sequencing )
• Bally, Marcel Bertran (Pancreas centre)
• Baumbusch, Jennifer (long-term residential care, family caregiving, Intellectual Disability, nursing care of older adults )
• Benard, Francois (Medical isotopes Radioisotopes Nuclear Medicine Cancer Imaging Molecular imaging of cancer Radionuclide therapy, Cancer division, radiology, pancreas centre)
• Bennewith, Kevin (Oncology; Molecular Pathology & Cell Biology; Cancer research; Solid tumour microenvironment; Hypoxia; Metastasis research; Pre-metastatic niche; Targeting hypoxic tumour cells in therapy; Radiation biology)
• Brooks-Wilson, Angela (Bioinformatics; Clinical oncology; Genetic medicine; Genomics; cancer families; cancer genetics; genetic susceptibility; human genetics; longevity; Super seniors)
• Brown, Carolyn Janet (Bioinformatics; Clinical oncology; Genetic medicine; Genomics; Health counselling; Applied Genetics; Chromosomes: Structure / Organization; DNA methylation; Epigenetic control of gene expression; Gene Regulation and Expression; Genes escaping X-chromosome inactivation; Long non-coding RNAs; X-chromosome inactivation; XIST RNA)
• Campbell, Kristin (Clinical oncology; Physical therapy; Rehabilitation medicine; Biomarkers; Breast Cancer; Exercise Physiology; oncology; physical function; Physiology; Quality of Life and Aging; rehabilitation)
• Cherkasov, Artem (Drug design; Bioinformatics, Molecular modeling; Proteomics; Artificial intelligence; Antibiotics )
• Collins, Colin (translational genomics where mathematics, genomics, computer science, and clinical science converge in diagnostics and therapeutics)
• Cox, Michael (genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer)
• Daugaard, Mads (Cancer progression and metastasis; Mechanisms of carcinogenesis; Cancer Diagnosis and Detection; Cancer biology; Cancer diagnostics; Cancer therapy; Cell Signaling and Cancer; Cell Therapy of Cancer; Chemotherapy; DNA damage response pathways; glycobiology; Immunotherapy; Radiotherapy; Cell stress and Cancer; Cell stress signalling in cancer)
• Dedhar, Shoukat (molecular biology, molecular biology as it relates to disease; developing new theraputics for cancer; how brain cells (neurons)make connections, therapeutics for cancer; molecular genetics and cancer; medical research, cancer, inflammatory diseases, cariovascular diseases, Cellular proteins, extracellular martrix, integrins, signal transduction, calreticulin, protein kinase, gene expression, cell differentiation)
• Dong, Xuesen (Cancer progression and metastasis; Gene and molecular therapy; Prostate Cancer; RNA splicing and Gene Regulation; Drug development; Hormone Dependent Cancers; Endocrine Regulation; Premature Labour)
• Drew, Yvette
• Evgin, Laura
• Garnis, Catherine (Cancer biology; Tumor progression; Oral premalignant lesions; Head and neck cancer; RNA biology, microRNAs; Alternative splicing; Biomarkers)
• Gleave, Martin (Infectious diseases, interdisciplinary oncology, prostate)
• Haase, Kristen (Nursing, n.e.c.; oncology; Older Adults; Geriatric oncology; Health systems research; Mixed Methods Research; Qualitative research; Self-management; E-health)
• Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
• Hirst, Martin (Bioinformatics; Clinical oncology; Genomics; Immunology; Microbiology; Carcinogenesis; Cellular Differentiation; Epigenomics; Leukemia; Molecular Genetics)
• Holt, Robert (Immunogenetics, Metagenomics - Infectious agents in Cancer, Cancer Genomes, Neurobiology, DNA Sequencing)
• Howard, Fuchsia (health service needs of vulnerable, high-risk survivors of acute life-threatening illness, specifically, cancer survivors and survivors of critical illnesses; hereditary cancer prevention and risk management and psychosocial and ethnocultural factors that shape health and illness experiences)
• Huntsman, David (hereditary cancer, molecular pathology, cancer biomarkers, Pancreas centre)
• Jiang, Xiaoyan (Cancer drug development and therapeutics)

Doctoral Citations

Sample thesis submissions.

• Investigation of the integrated stress response and its downstream pathways as a pro-tumorigenic mechanism in pediatric embryonal tumors
• Combining DNA-PK inhibitors with DNA-damaging therapies expands the targeted cell population to kill more cancer cells but also elevates toxicities in normal cells
• New approaches to targeting transcription factors in hormone-dependent cancers
• Semaphorin 3c (SEMA3C) as a potential therapeutic target in breast cancer
• The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes and HIF1α accumulation
• The modification of chimeric antigen receptor T cells to overcome immune suppression mediated by indoleamine 2,3-dioxygenase
• ARID1A-loss in cancer causes R-loop mediated genome instability and sensitizes cells to KEAP1 perturbation
• From MYCN to inflammaging : understanding the pathogenesis of immature T-ALL
• Molecular characterization of MET splice mutant receptor signaling as a driver of lung adenocarcinoma
• The interplay of Carbonic Anhydrase IX and the glutamine transporter SLC1A5 in the hypoxic tumor microenvironment
• Proliferating cell nuclear antigen ubiquitination as a central regulator of transcriptional stress
• The role and regulation of PPARγ expression in muscle invasive bladder cancer
• Identification and characterization of primitive fetal hematopoietic cells
• Development of Zein nanoparticles for in vivo use : proof of concept and preliminary investigation of X-Ray triggered drug release
• Exploring mechanisms of T-cell acute lymphoblastic leukemia pathogenesis through molecular characterization of normal T-cell development

Related Programs

Same specialization.

• Master of Science in Interdisciplinary Oncology (MSc)

Further Information

Specialization.

Interdisciplinary Oncology offers advanced study and research in a variety of fields relating to oncology. The focus on interdisciplinarity is accomplished through a breadth of coverage in the following disciplines: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, socio-behavioural studies, and epidemiology.

UBC Calendar

Program website, faculty overview, academic unit, program identifier, classification, supervisor search.

Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update contact details for application inquiries, please use this form .

Ariene Cabantog

I spent my childhood in various parts of the world but ultimately made British Columbia my home. When deciding where to pursue my undergraduate degree, I knew that staying in BC was important to me - I loved the proximity to the ocean and the mountains, and I wanted to be near my family. UBC stood...

Courtney van Ballegooie

I chose UBC for several reasons, including its reputation as a research institute and diverse program selection. UBC is a globally recognized university with a high degree of renowned researchers. Having the ability to pursue a PhD with the support of my supervisors, Drs. Marcel Bally and Donald...

Start calling Vancouver “Home”

The metropolitan area is known for its diversity and UBC is one of the most international universities in Canada. This multicultural community means we have a wide range of restaurants, grocery stores, and events to provide a sense of belonging.

• Why Grad School at UBC?
• Application & Admission
• Info Sessions
• Research Projects
• Indigenous Students
• International Students
• Tuition, Fees & Cost of Living
• Newly Admitted
• Student Status & Classification
• Student Responsibilities
• Supervision & Advising
• Managing your Program
• Health, Wellbeing and Safety
• Professional Development
• Dissertation & Thesis Preparation
• Final Doctoral Exam
• Final Dissertation & Thesis Submission
• Life in Vancouver
• Vancouver Campus
• Graduate Student Spaces
• Graduate Life Centre
• Life as a Grad Student
• Graduate Student Ambassadors
• Meet our Students
• Award Opportunities
• Award Guidelines
• Minimum Funding Policy for PhD Students
• Killam Awards & Fellowships
• Policies & Procedures
• Information for Supervisors
• Dean's Message
• Leadership Team
• Strategic Plan & Priorities
• Vision & Mission
• Equity, Diversity & Inclusion
• Initiatives, Plans & Reports
• Graduate Education Analysis & Research
• Media Enquiries
• Newsletters
• Giving to Graduate Studies

Strategic Priorities

• Strategic Plan 2019-2024
• Improving Student Funding
• Promoting Excellence in Graduate Programs
• Enhancing Graduate Supervision
• Advancing Indigenous Inclusion
• Supporting Student Development and Success
• Reimagining Graduate Education
• Enriching the Student Experience

Initiatives

• Public Scholars Initiative
• 3 Minute Thesis (3MT)
• PhD Career Outcomes

• My UCalgary
• Class Schedule
• UCalgary Directory
• Continuing Education
• Active Living
• Academic Calendar
• UCalgary Maps
• Close Faculty Websites List Viewing: Faculty Websites

Cumming School of Medicine

• Faculty of Arts
• Faculty of Graduate Studies
• Faculty of Kinesiology
• Faculty of Law
• Faculty of Nursing
• Faculty of Nursing (Qatar)
• Faculty of Science
• Faculty of Social Work
• Faculty of Veterinary Medicine
• Haskayne School of Business
• School of Architecture, Planning and Landscape
• School of Public Policy
• Schulich School of Engineering
• Werklund School of Education
• Future Students
• Explore programs
• How to apply
• Understanding graduate studies
• Indigenous graduate students
• Financing grad school
• International students
• Graduate Student life
• Current Students
• Indigenous Graduate Students
• Newly Admitted
• Graduate Orientation
• Pre-arrival
• Registration
• Annual Registration
• Concurrent Registration
• Flexible Grading Option (CG Grade)
• Confirmation of registration
• Course registration
• Leave of absence
• Registration status
• Studying at another university
• Updating personal information (included preferred name)
• Thesis-based students

Fees and funding

• Understanding your fees
• Paying your fees
• Funding options
• Payment plan
• Supervision
• Best practices and guidelines
• Conflict of interest
• Changing supervision
• Academic integrity
• Annual progress report
• Intellectual property
• Building a thesis
• Submit your thesis
• Conducting oral exams remotely
• Thesis defence
• Course-based Students
• Academic Integrity
• Sources of funding
• Payment Plan
• NEW: Term-Based Registration
• Completing my degree
• Important dates and resources
• Forms and documents
• Service Requests and eForms
• News, updates and events
• Find your Graduate Program Administrator
• Calendar Archives
• Award Opportunities
• Graduate Awards Database
• Award opportunities
• Doctoral Recruitment Scholarships
• Award Guide
• Step 1: Applying
• Looking for awards
• Eligibility
• Preparing your application
• Step 2: Receiving
• Accept/Decline your award
• Getting paid
• Step 3: Managing your award
• Renewing your award
• Award interruption
• Award Termination
• Policies and Regulations
• Regulations
• Contact the Scholarship Office
• My GradSkills
• Academic Success
• My GradSkills Partners
• Communication Skills
• Research Communications Feedback Sessions
• Oral communication
• Visual communication
• Written communication
• Experiential Learning
• Internships
• For employers
• For graduate students
• Finding an internship
• Making your internship a TTI
• Applying for a TTI
• For graduate supervisors
• Images of Research
• Three Minute Thesis
• 2024 UCalgary 3MT Finalists
• 2024 3MT Finals' Hosts and Judges
• Past Three Minute Thesis Videos
• Workshops and Resources
• Career planning and professional development resources
• My GradSkills Calendar
• My GradSkills Workshop Matrix
• Online/Virtual Training
• UCalgary Alumni Mentorship Program
• Exceptional scholars
• What I wish I knew
• FGS Services
• Supervisory Renewal
• Supports for graduate students
• Graduate Academic and International Specialists
• Graduate supervisors
• Thesis and candidacy exams
• Supervisor resources
• Maintaining your supervisor profile
• Supervisory privileges
• Leadership team
• FGS Council
• Committees of Council
• Minutes and meetings
• Website Feedback

Medical Science

Doctor of Philosophy

Thesis-based program

Program overview.

For over 40 years the graduate program in Medical Science has prepared students for independent scientific careers in academic and non-academic settings. Graduates of the doctoral program have a strong record of excellence in obtaining post-doctoral positions often leading to faculty appointments or jobs in industry at leading institutes across Canada and around the world.

One of the University of Calgary's largest graduate programs, Medical Science offers specializations ranging from cancer biology and critical care to molecular and medical genetics (but training is not limited to these specialties). Our program is supported by collaborations with related programs throughout the Cumming School of Medicine and the University of Calgary.

Completing this program

Courses:  Topics will be determined according to the student's research area.

Research Ethics:  Students are required to attend Research Integrity Day sessions in the first year of their program.

Seminars: Students will participate in a research in progress semina and journal club relevant to their program.

Research Proposal:  Students must defend a written research proposal to their supervisory committee.

Candidacy: Students will complete both oral and written candidacy exams.

Thesis:  Students will be required to submit and defend an original research thesis.

Specializations

• Cancer Biology
• Critical Care Medicine
• Joint Injury & Arthritis Research
• Biomedical Ethics
• Molecular & Medical Genetics
• Mountain Medicine and High Altitude Physiology

Academic researchers, education, medicine, government agencies, health organizations, and the private sector/industry; biotechnology start-up companies, clinical trials, research-oriented positions in pharmaceutical/biotech companies and Fortune 500 businesses.

A PhD in medical science is usually considered a final degree; many graduates pursue post-doctoral research.

Students are required to prepare a thesis and successfully defend in an open oral defense.

Three courses

Learn more about program requirements in the Academic Calendar

Classroom delivery

Time commitment.

Four years full time; six years maximum

A supervisor is required; potential supervisors must be listed when applying to the program

See the Graduate Calendar for information on  fees and fee regulations,  and for information on  awards and financial assistance .

Virtual Tour

Explore the University of Calgary’s (UCalgary) Foothills Campus from anywhere. Experience all that the Cumming School of Medicine has to offer for interested prospective graduate students. Explore this state of the art campus from wherever you are. Discover the buildings, student services and available programs all from your preferred device.

Supervisors

Learn about faculty available to supervise this degree.

Jean Addington

Herman Barkema

Cheryl Barnabe

Kathryn Birnie

Janice Braun

Linda Carlson

Kris Chadee

Carla Coffin

Alastair Cribb

Admission Requirements

A minimum of 3.3 GPA on a 4.0 point system, over the past two years of full-time study (a minimum of 10 full-course equivalents or 60 units) of the undergraduate degree.

Minimum education

An MSc or other relevant Master's degree.

Work samples

Reference letters, test scores, english language proficiency.

An applicant whose primary language is not English may fulfill the English language proficiency requirement in one of the following ways:

• Test of English as a Foreign Language (TOEFL ibt)  score of 105.
• International English Language Testing System (IELTS)  score of 7.5 (minimum of 6.0 in each section)
• Pearson Test of English (PTE)   score of 75, or higher (Academic version).
• Canadian Academic English Language test (CAEL)  score of 70 (minimum 70 in each section)  
• Academic Communication Certificate (ACC)  score of A- in each course.
• Cambridge C1 Advanced or Cambridge C2 Proficiency  minimum score of 200.
• Duolingo English Test  and obtaining a minimum score of 145* (with no sub-score below 125*). ( temporary until Fall 2024 intake )

For admission on May 1:

• Canadians and permanent residents: Mar. 1 application deadline
• International students: Dec. 1 application deadline

For admission on Sept. 1

• Canadians and permanent residents: June 1 application deadline
• International students: Apr. 1 application deadline

For admission on Jan. 1

• Canadians and permanent residents: Oct. 1 application deadline
• International students: Aug. 1 application deadline

If you're not a Canadian or permanent resident, or if you have international credentials, make sure to learn about international requirements

Are you ready to apply?

Learn more about this program, medical science - graduate studies.

Health Sciences Centre, HSC G341C 3330 Hospital Drive NW Calgary, AB T2N 4N1

Contact the Graduate Program Administrator

Visit the departmental website

Health Sciences Centre Foothills Campus, University of Calgary Calgary, AB T2N 4N1

Visit the Cumming School of Medicine website

Learn more about UCalgary by taking a virtual tour

Related programs

If you're interested in this program, you might want to explore other UCalgary programs.

Thesis-based MSc

Biochemistry and Molecular Biology

Biomedical technology.

Course-based MBT

Cardiovascular and Respiratory Sciences

Community health sciences, gastrointestinal sciences, microbiology and infectious diseases, neuroscience, pathologists' assistant.

Course-based MDPA

Curious about the University of Calgary?

Located in the nation's most enterprising city, we are a living, growing and youthful institution that embraces change and opportunity with a can-do attitude.

Research | Queen’s University Canada

Custom search form, queen's log in links.

• MyQueen'sU - SOLUS, MyHR and more
• Outlook on the web - Email
• Course Reserves
• Business - Program Portals
• Education - Faculty & Staff Portal
• Grad Studies – Faculty & Staff Portal
• Medicine - Elentra

Search/Login Toggle

• Queen's Research Facts
• Path to the Nobel Prize
• More than 175 years of Research
• Vice-Principal Research Portfolio
• Feature Stories and Articles
• Research Radio
• The Art of Research Photo Gallery
• Research Video Gallery
• News and Events
• Canada Research Chairs
• Endowed Chairs
• Student Researchers
• Research Awards
• Centres and Institutes

Cancer Research Institute

• Share on Facebook
• Share on Twitter
• Share on LinkedIn
• Share via Email

Founded in 2001, the Queen's Cancer Research Institute (QCRI) has grown into the largest research concentration in the Faculty of Health Sciences.

Research at the 60,000-square foot facility ranges from population studies of cancer etiology, through tumour biology and clinical trials, to outcomes, and health services research. The QCRI is committed to improving cancer control through research that spans disciplines and investigates connections among fundamental, clinical, and population research.

The QCRI is home to three divisions that conduct cancer research at different scales, ranging from single molecules to populations in Canada and across the globe:

The Cancer Biology and Genetics Division carries out molecular, cellular, genomic, and translational studies in cancer diagnostics, mechanisms of tumour progression, and in drug development, metabolism, and resistance.

The Cancer Care and Epidemiology Division (CCE) investigates the etiology of cancer as well as strategies to improve access to high-quality care for patients in Canada and beyond.

The Canadian Cancer Trials Group (CCTG) , the country’s premier cooperative oncology group, carries out investigator-initiated clinical trials featuring a diverse portfolio of therapeutic, supportive care, and prevention strategies in all age groups and all cancer types. The CCTG has two main areas of study: investigational new drugs and comparative randomized trials.

• Partnerships
• Student Opportunities

The QCRI engages with a variety of commercial and academic partners around the world. Within Canada, more than 80 institutions participate in the clinical trials run through the CCTG network, which also links to trial networks in the United States, Europe, Australia, New Zealand, Japan, and Korea.

CCE works extensively with Cancer Care Ontario and the Institute for Clinical and Evaluative Sciences. Both CCTG and CBG have significant partnerships with the Ontario Institute of Cancer Research, including two initiatives lead by Queen’s researchers: the Canadian Cancer Clinical Trials Network and the Ontario Molecular Pathology Research Network.

The QCRI offers opportunities for undergraduate, graduate, and post-doctoral training in partnership with several departments at the university, including Biomedical and Molecular Sciences, Community Health and Epidemiology, Mathematics and Statistics, Oncology, Pathology and Molecular Medicine, and the Queen's School of Policy Studies.

QCRI also operates a training program in transdisciplinary cancer research that is tailored to meet the needs of graduate and post-doctoral trainees from a wide range of clinical and research disciplines.

Related Stories

Where medical science meets patients

One Step Closer to Unravelling Cancer

Evolving Clinical Trials through Collaboration

Trials help clinicians face even the most daunting disease

Calculating the real value of clinical trials

Finding quality of life amidst quantity of data

Cell and cancer biology

Researchers.

Researchers study how cancer cells repair their DNA, regulate their genes, differentiate, migrate, and recruit blood vessels in order to uncover both the mechanisms of disease as well as identify new therapeutic targets. This work is often conducted collaboratively, with clinicians providing insights from patients and basic scientists studying the molecular and cellular basis of the disease.  At the same time, they also investigate existing therapeutics to identify factors that may predict which patients are most likely to benefit and to determine how their application might be improved.

Adam Rudner

The  Rudner laboratory  focuses on understanding fundamental problems of chromosome dynamics. Defects in chromosome structure and segregation can lead to chromosome loss and damage, both critical events in the development of cancer and chromosomal disorders. 

Barbara Vanderhyden

The  Vanderhyden lab  studies many aspects of ovarian cancer, including the role of specific genes in human ovarian cancer initiation, progression, chemo-sensitivity and prognosis. They create model systems of ovarian cancer to study disease initiation and to test the therapeutic efficacy of novel anti-cancer drugs. They are particularly interested in the role of stem cells in the ovarian and oviductal epithelia and their contribution to cancer initiation. With a growing interest in chromatin remodeling proteins, they are exploring the roles of these proteins in reproductive tissues, including ovary, placenta and embryonic stem cells.

Christine Pratt

NF-κB has critical roles in normal organogenesis, the immune system and cancer. Research in  Dr. Pratt’s lab  over the past several years has focused on the role that NF-κB plays in various forms of breast cancer. To study this, she utilizes both mouse models and mammary epithelial and tumor cell lines to dissect relevant signaling pathways.

Derrick Gibbings

RNA is not just the intermediate between DNA and protein. RNA acts as a post-transcriptional regulator, enzyme and ligand. In these multiple roles, RNA has critical impacts in cancer, neuromuscular disease and viral infection. The broad theme of  Dr. Gibbings’  research program is to understand how RNA is regulated in the context of a complex cellular environment. Often, for simplicity, we portray processes involving RNA as occurring in a cytoplasmic void governed by random encounters. The lab aims to understand the complex life of RNA in a dense cellular milieu interacting with vesicles, organelles and regulatory complexes in the context of disease.

Douglas Gray

The central interest of the  Gray laboratory  is the regulation of protein stability and how a decline in proteolytic efficiency contributes to age-related diseases such as cancer and neurodegeneration.  One area of particular interest is the role of deubiquitinating enzymes such as USP4 (which was discovered in the Gray laboratory), and the closely related enzymes USP15 and USP11.  These enzymes have documented roles in different malignancies, and we are studying the evolution of this gene family in an attempt to determine how their substrate specificities arose.

Jean-Simon Diallo

Dr. Diallo  is an Associate Scientist at the OHRI working with a multidisciplinary network of collaborators, he and his team are using medicinal chemistry, mass spectrometry and high-throughput molecular biology approaches to study how “viral sensitizer” drugs work. He is also expanding the scope of application of viral sensitizer drugs, which in addition to oncolytic virotherapy, show tremendous promise in virus/vaccine manufacturing and gene therapy applications.

John WR Copeland

Dr. Copeland’s laboratory  investigates the role of the formin family of cytoskeletal remodeling proteins in governing cellular dynamics. Current projects focus on the role of FMNL2 in melanoma metastasis, the role of formins in cell-cell junction formation in endothelial cells, and the role of the novel formin INF1 in Golgi and primary cilium assembly

Jonathan Lee

The lab  is broadly interested in breast cancer and the molecular biology of cell motility. To study these processes we use state-of-the-art technologies: bioinformatics, proteomics, high-resolution fluorescence microscopy, live cell microscopy and protein biochemistry to name a few. There are two ongoing research themes in the lab which include the remodeling of the actin cytoskeleton during cell migration and the role of the lipid kinase PI4KB in breast cancer.

Laura Trinkle-Mulcahy

Dr. Trinkle-Mulcahy  is a cell biologist who uses a unique combination of fluorescence microscopy and quantitative proteomics to map the targeting of protein phosphatase complexes throughout the cell. These key enzymes contribute to the regulation of nearly all cellular signaling pathways; aberrant phosphorylation is a causative factor in a range of human diseases. A greater understanding of their regulation at the cellular level is thus essential for the development of therapeutic strategies targeted at these dysfunctional pathways.

Lisheng Wang

Using cellular and molecular approaches and in vivo animal models,  Dr. Wang’s laboratory  is interested in nurturing human embryonic stem cells (hESCs) into mothers of circulatory cells and immune cells, generating transplantable cells for stem cell-based clinic therapy and reducing transplantation rejection. His laboratory is working on the targeting of embryonic signaling pathways in cancer for more effective treatment.

Ryan Russell

The  Russell lab  focuses on discovering the mechanisms underlying autophagy regulation in normal and pathological tissues. The autophagy pathway is the primary catabolic process in the cell, maintaining the integrity of organelles and the proteome.  Additionally, autophagy promotes survival in response to depletion of cellular nutrients, DNA damage and hypoxia (low oxygen). Dysregulation of autophagy has been observed in several diseases including; cancer, Crohn’s disease and neurodegeneration.

Stephen Gee

The overall goal of  Dr. Gee’s research  program is to understand how lipid signals impinge upon the actin cytoskeleton to regulate fundamental cellular processes such as cell shape, movement and the uptake of nutrients. The lab’s main focus is the study of an enzyme called diacylglycerol kinase zeta (DGKζ), which phosphorylates the lipid second messenger diacylglycerol (DAG) to yield phosphatidic acid (PA), both of which have important signaling roles in cells. Dr. Gee’s lab is currently using a combination of biochemistry, cell and molecular biology, and advanced microscopic methods to study the role of DGKζ role in cancer cell migration, axon outgrowth and guidance, and skeletal muscle cell fusion and hypertrophy.

Tommy Alain

Surgery, chemotherapy and radiotherapy are the current standard-of-care treatments against cancer. A considerable number of cancers cannot be treated simply using the current available treatments. Scientists at University of Ottawa are working hard to devise new treatments based on an entirely different approach that involves the use of viruses to destroy human cancer. Dr. Alain laboratory is interested in understanding how these viruses modulate the gene expression of cancer cells thus contributing to the cancer demise. Gene expression is the cell’s program by which it synthesizes its various cellular components. We are currently investigating how oncolytic viruses modulate the gene expression program, specifically the process of mRNA translation.

Marjorie Brand

Dr. Brand’s  research focuses on the regulation of gene expression at the level of transcription and chromatin/epigenetics. Her laboratory uses a combination of in vitro (proteomics, genomics) and in vivo (leukemia mice models, xenotransplantation of human leukemic cells in immunodeficient mice) approaches to understand how hematopoietic stem cells differentiate into blood cells and how deregulation of this process causes leukemia.

Dr. Cowan's  laboratory looks at the role of elastases, matrix metalloproteinases, and the extracellular matrix in the progression of pulmonary vascular disease associated with congenital diaphragmatic hernia.  Dr. Cowan  is also looking at the use of a stem cell approaches to treat pulmonary vascular diseasees associated with congenital diaphragmatic hernia as well as the role of pannexins in the regulation of skeletal muscle differentiation and tumourigenesis associated with rhabdomyosarcoma to identify potential new therapeutic targets

Chantal Matar

Dr. Matar’s  research is focused on biomedical issues related to nutrition/immunology/cancer and how peptides and probiotics impact mucosal and tumoral immunity. Many aspects of the research involve in vivo assessments of immunomodulatory substances in mouse models and studying immunosurveillance against tumours and mucosal infections. Her lab is also specialized in analyzing biopeptide-mediated immune modulation in mucosal immunity, chemoprevention of mammary carcinoma and studying the molecular pathways involved in the immunopotentiating effect.

Lynn Megeney

Dr. Megeney’s  lab studies the molecular mechanisms that control cell adaptation and cell differentiation. They are particularly interested in the biology of cell death proteins and how these factors are redeployed to promote these beneficial cellular functions. Dr. Megeney’s laboratory has focused on the role of the pro-death caspase protease family, a group of enzymes that target and cleave a large number of protein substrates. They utilize a broad range of model systems to interrogate caspase biology including yeast, mammalian cell culture and transgenic animal studies. Their long-term goals are to identify the constraints and substrates that allow caspase enzymes to promote stem cell maturation (differentiation) and act as beneficial remodeling agents during cell stress. 

Luc Sabourin

The Sabourin laboratory  is looking at the role of the Ste20-like kinase (SLK) in cancer cell motility. His research also focuses on understanding how much growth factor receptors, such as ErbB-2 (overexpressed in 25-30% of human breast cancers) and c-Met are coupled to extracellular matrix signaling and to the migration machinery using transgenic models and cell culture systems. He believes that delineating the molecular mechanisms translating growth factor signals to the migration machinery is key in the development of additional therapies targeted at the invasive potential of these tumors.

Duncan Stewart

The  Stewart Lab  is focused on translational research utilizing stem/progenitor cells for the treatment of cardiopulmonary and vascular diseases, together with enhancement strategies to increase their regenerative activity and overcome the deleterious effects of aging and attendant cardiac risk factors. Ongoing projects range from basic science discovery research on novel mechanisms of pulmonary hypertension and the role of exosomes in mediating the therapeutic effects of stem cells in vascular disease, to translational research including clinical trials on gene-enhanced progenitor cell therapy for acute myocardial infarction and immunomodulatory cell therapy for septic shock. The role of endothelial factors, such as nitric oxide and angiopoietins, in vascular health and disease, as well as angiogenesis and neovascularization, continues to be a central focus for Dr. Stewart’s laboratory.  

Yannick Benoit

Dr. Benoit’s  laboratory aims to describe the fundamental epigenetic phenomenon governing stem cell identity in the human intestinal epithelium and colorectal tumours. One of the main goals of the laboratory is to develop novel, anticancer agents targeting key epigenetic features of colorectal cancer stem cells. Moreover, Dr. Benoit aims to tackle the barrier of knowledge regarding the physiological role of chromatin organization in human intestinal stem cell identity and dynamic plasticity.

Damien D’Amours

Dr. D’Amours’  research program looks at the mechanisms that control cell cycle progression and genome stability in eukaryotes. In particular, we aim to reveal how cells divide their genome during mitosis and how they repair their chromosomes in the presence of DNA damage. His laboratory uses cutting edge proteomics and genomics analyses to identify novel effectors of chromosome stability and regulator of cell cycle checkpoints. Using a systems biology approach, our laboratory has provided critical new insights into the mechanisms responsible for the maintenance of genome integrity in health and disease states with a particular focus on the genesis of cancer and its resistance to chemotherapy.

Christina Addison

Dr. Addison’s  research program focuses on two main themes; 1) the role of the tumour extracellular matrix (ECM) microenvironment in modulating tumour growth and angiogenesis and 2) cancer biomarker discovery. Her laboratory actively investigates the role of the ECM in modulating the growth of tumours and their response to common anti-cancer treatments. As the ECM present in tumors is vastly different than that found in normal tissue counterparts, understanding the effects of ECM on endothelial cell and tumor cell biology is extremely important. To this end she is also investigating the molecular events responsible for this modulation including the role of focal adhesion kinase and integrin linked kinase signal transduction pathways.

Rebecca Auer

Despite the removal of the solid tumor, such as colon cancer, the cancer will come back after surgery, often spreading to distant organs. Owing to physiological stresses incurred to the tissues during surgery, it is recognized that such procedures induce the spreading of cancer. Many patients get toxic treatments, such as chemotherapy, many weeks after surgery to try and prevent this.  Dr. Auer’s  research is focused on trying to understand why tumour cells spread after surgery and develop new approaches to prevent this.

Dr. Bell’s  research program is directed towards the identification and characterization of novel cancer killing therapeutic viruses that selectively infect and kill cancer cells, while leaving healthy cells and tissues unharmed. Not only did his laboratory discover and design these therapeutic viruses, but he also manufactures them for eventual clinical translation and commercialization.

Jim Dimitroulakos

Dr. Dimitroulakos laboratory has two main research themes revolving around the identification of novel therapeutic approaches in the treatment of epithelial cancers including lung, head and neck and prostate carcinomas. The first research theme stems from the discovery that inhibiting the mevalonate pathway, involved in de novo cholesterol synthesis, can induce tumour specific killing. The second research theme is to identify novel mechanisms of action to common chemotherapies particularly the platin family of drugs. Although platins demonstrate activity in various tumour types, acquired or intrinsic resistance mechanisms limit their efficacy. One research project seeks to study a cellular stress pathway regulated by the activating transcription factor 3 (ATF3) as a key regulator of platin cytotoxicity. Understanding the role of this pathway in regulating platin-induced tumour cell killing and developing drugs that target this pathway to enhance platin efficacy will have therapeutic benefit.

Robert Korneluk

Dr. Korneluk’s laboratory is investigating the role of the Inhibitor of Apoptosis (IAP) gene family in the regulation of programmed cell death, also known as apoptosis. His group is investigating the role of IAPs – in particular, XIAP, cIAP1 and cIAP2 – in the progression of cancer, and exploring the use of small molecular IAP antagonists for cancer treatment. A particular focus is on the use of small molecular antagonists to enhance cancer treatment. His laboratory is also investigating the roles of the IAPs in muscle biology and disease. These studies will add insight into normal and disease processes involved in myogenesis and muscle repair in wasting syndromes such as muscular dystrophy, atrophy and cancer-induced cachexia.  

Ian Lorimer

Dr. Lorimer’s  research program revolves around the phosphoinositide 3-kinase pathway in cancer. His laboratory studies this pathway to identify and evaluate novel targets for cancer therapy. His recent work has focused on the role of protein kinase C; a protein initially known for its role in cell polarity and now also recognized for its role in promoting proliferation, invasion and resistance to chemotherapy in cancer cells. Currently a major focus of his lab is to characterize the role of the phosphoinositide 3-kinase pathway in tumour-initiating cells isolated from brain tumors.

David Stojdl

Cancer can be considered as the corruption of normal biological programs that control cell proliferation, metabolism, death, motility, stickiness and immune functions.  Dr. Stojdl  aims at harnessing the natural world of viruses to fight cancer. His laboratory designs and develops programmable replicating viruses called ‘oncolytic viruses’ as biotherapies that directly target cancer cells and activate a patient’s own immune system against their tumor.

Xiaohui Zha

Cholesterol is long known to be a necessary building block for mammalian cell membranes. In recent years, it is also widely appreciated that cholesterol plays a critical role in forming lateral membrane nano-domains. These domains facilitate protein/protein interactions, whereby providing central hubs for signal transduction. The focus of  Dr. Zha’s  laboratory is the study of cholesterol transport and membrane dynamics in mammalian cells. Her laboratory hopes to gain insights into the functions of cholesterol at the cellular level. Her laboratory employs novel biophysical and biochemical techniques to study these domains and link them to physiological cellular functions. Her lab currently focuses on one of the cholesterol transport proteins, ATP-binding cassette protein A1 (ABCA1); a protein for which mutations give rise to the Tangier disease.

Michele Ardolino

The immune system is an incredible weapon against tumors and yet, cancer is still one of the leading causes of death. It is of extreme importance to have a more detailed knowledge of the complex interactions between immune cells and cancer in order to design more tailored and effective immunotherapies.  Dr. Ardolino’s  group is interested in understanding why a subset of immune cells named Natural Killer (NK) cells are often able to kill tumor cells and to find new ways to harness the activity of NK cells against cancer. Currently, his lab is focusing on: 1. determining the functions of checkpoint receptors on NK cells. 2. understanding the cellular networks that suppress the NK cell response to cancer. 3. deciphering the molecular pathways responsible for suppressing NK cell activation in the tumor microenvironment.

Julie St-Pierre

The central research focus of the  St-Pierre  laboratory is understanding metabolic adaptation to physiological and pathological conditions. They are particularly interested in the plasticity of mitochondrial functions and how they contribute to overall energy homeostasis. Her team has contributed significantly to understanding the role of the master regulators PGC-1s in cancer, with a particular focus on poor outcome breast cancers. Her laboratory showed that PGC-1alpha plays a key role in setting the metabolic state of poor outcome breast cancers and that it promotes breast cancer growth. Recently, she is pursuing the investigation of the role of PGC-1s in breast cancer progression and other research projects on metabolic adaptations fueling metastasis and therapeutic resistance.

Areas of research

Microbiology and immunology

Stem cell biology and organismal development

Systems biology and chemical biology

Neurobiology

Molecular basis of neuromuscular diseases and myopathies

Metabolic disorders

Study and Work in Oncology in Canada

Graduate Oncology Admission Requirements The prequisites required to become accepted in an graduate and/or post-graduate PhD program in Oncology.

What Oncology Students Learn Topics and concepts that are covered and the overall approach or focus taken in studying Oncology.

Research in Oncology Research areas, topics, interests projects in Oncology.

Career and Employment Opportunities in Oncology Professions or occupations available to graduates in Oncology and links to employment resources.

Copyright 2021 - Hecterra Publishing Inc. - Privacy Statement - Terms of Service

Cancer is the leading cause of premature death in Canada.

Each year, there will be more than 175,000 new cases and approximately 75,000 deaths from this disease. This means that every day, an estimated 500 Canadians will be diagnosed with cancer and another 200 will die.

To improve cancer treatment and reduce the burden of this disease, our researchers strive to expand their understanding of cancer biology.

By using multi-disciplinary approaches, they elucidate the underpinnings of cancer hallmarks and translate these discoveries into novel cancer therapeutics. 

Our researchers focus on various aspects related to key hallmarks of cancer such as: 

• genome instability and alterations
• cell death resistance
• proliferative signalling
• evasion of growth suppressors
• invasion/metastasis
• replicative immortality
• angiogenesis
• energy metabolism
• cancer stem cells
• inflammation and immune evasion

Latest news on Cancer research

Team effort reveals cells reshape their nucleus to repair DNA, impacting cancer and aging

Resident Doctor Q&A: Dr. Trevor Teich

Resident Doctor Q&A: Dr. Ruchika Gupta

Resident Doctor Q&A: Dr. Sarah Khan

LMP innovations storm Angel’s Den

Humans of LMP: Boris Virine

Jump to navigation

Search form

Princess margaret cancer centre, publications annually.

• Appointments and Promotions
• Documents and Forms

The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers and cutting-edge research infrastructure. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre). PM Cancer Centre’s researchers are grouped into the following programs based on their research:

The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers and cutting-edge research infrastructure. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre). PM Cancer Centre’s researchers are grouped into the following categories based on their research program:

• Cancer Biology and Imaging
• Computational Biology and Medicine
• Genetics and Epigenetics
• Immuno-Oncology
• Protein Structure and Function
• Supportive Care

PMResearch@uhnresearch.ca

Research Directorate, Princess Margaret Cancer Centre 610 University Avenue Toronto, ON M5G 2M9 CANADA

Built on the long tradition of exemplary research expertise, PM Cancer Centre's Cancer Biology and Imaging multidisciplinary program is committed to themes in cell, molecular and mechanistic biology of cancer, molecular pathology, personalized molecular cancer imaging and cancer models. The collaborative nature of the program aims for transforming discoveries and rapid translation through scientific innovation, research integration and clinical implementation.

Scientist, Senior Scientist, Clincian Scientist 

Harding, Shane   (Chair)

Ailles, Laurie

DaCosta, Ralph

Done, Susan

Hakem, Razq

Irish, Jonathan

Kirsch, David

Koritzinsky, Marianne

Lilge, Lothar

Liu, Fei-Fei

Lok, Benjamin

Rottapel, Robert

Stambolic, Vuk

Trudel, Suzanne

Vitkin, Alex

Wilson, Brian C

Wouters, Bradly

Zheng, Gang

Affliate Scientist 

Zacksenhaus, Eldad

Adjunct Scientist 

Nixon, Kevin

Salmena, Leonardo

Emeritus Scientist 

Boyd, Norman

Hedley, David

Rauth, Mike

Staff Scientist

Jonkman, James

The Computional Biology and Medicine Program (CBMP) is home to Scientists and Clinicians interested in computational methods used to aggregate, analyze and share biomedical data for basic, translational and clinical research. By assessing how emerging computational technologies can be leveraged to address scientific and clinical gaps, CMBP will work toward the dissemination of multimodal data and software tools, education regarding their use, alignment with internal and external initiatives, and foster synergies within and across programs .

For more information, visit  https://cbmp.ca/  or contact Paul Brogee (Program Manager; Paul.Brogee@uhnresearch.ca ).

Scientist, Senior Scientist, Clinician Scientist

Hoffman, Michael  (Chair)

Brudno, Michael

Gaiti, Federico

Haibe-Kains, Benjamin

Kumar, Sushant

Liu, Geoffrey 

Pugh, Trevor

Schwartz, Gregory

Seuntjens, Jan

Affiliate Scientist

Bader, Gary

Emeritus Scientist

Minden, Mark

Adjunct Scientist

Moran, Michael

Clinical Champion

Bedard, Philippe

Berlin, Alejandro

Cescon, David

Grant, Robert

Haider, Masoom

Hope, Andrew

Kridel, Robert

Leighl, Natasha 

The Genetics and Epigenetics Program focuses on the fundamental genetic, epigenetic, and genomic mechanisms underlying cancer development, progression, and treatment, with the aim of translating basic research discoveries and new technologies into clinical application. The goals of this program are to align and synergize research within the team, facilitate collaborations between basic research and clinical groups, build genetic and epigenetic platforms and resources, and prepare the team for internal and external grant applications.

Scientist, Senior Scientist, Clinician Scientist 

Lupien, Mathieu  (chair)

Bratman, Scott

De Carvalho, Daniel

He, Housheng (Hansen)

Kim, Raymond

Nguyen, Long

Notta, Faiyaz

Penn, Linda

Shepherd, Frances

Siu, Lillian

Stewart, Keith

Tsao, Ming-Sound

Zadeh, Gelareh

Assistant Scientist

Bunda, Severa

Chen, Eric (Xueyu)

Moghal, Nadeem

Ketela, Troy

Orouji, Elias 

Clinical Champion 

Berman, Hal

Fleshner, Neil

Gallinger, Steven

van der Kwast, Theo

The immune therapy program will make cutting edge contributions to the field of immune-oncology by uncovering novel findings in basic and translational research, as well as learning from patient responses in clinical trials to improve response rates and quality of life. Our goal is also to develop novel technologies and reagents to remain at the forefront of this field.

Hirano, Naoto  (Chair)

Brooks, David

McGaha, Tracy

Ohashi, Pamela

Reedijk, Michael

Affiliate Scientist 

Sacher, Adrian

Paige, Christopher

Staff Scientist 

Nguyen, Linh

Gerbitz, Armin

Saibil, Sam

We aim to understand the molecular "machines" that perform the critical cellular processes impacted in cancer related diseases. Using a variety of cutting-edge technologies to characterize the regulation, structure and function of proteins that drive, or are affected by, cancer, we aim to identify new therapeutic targets and biomarkers, and to develop new tools to target protein functions linked to disease. 

Arrowsmith, Cheryl H  (Chair)

Diamandis, Phedias

Ikura, Mitsuhiko

Kislinger, Thomas

Mazhab-Jafari, Mohammad

Prive, Gilbert G

Raught, Brian

Zarrine-Afsar, Arash

Rose, David

Marshall, Chris

Seabrook, Genevieve

The focus of the Stem Cell Program is the functional interrogation of normal and malignant stem cells at both the clonal and molecular level. Our strategy being to identify genetic and non-genetic drivers that maintain cancer cells in a stem-cell state and thereby sustain tumour growth. The overarching goal of the stem cell program is to translate our discoveries into novel therapeutic strategies designed to target cancer stem cells and as a result improve outcomes for cancer patients.

Hope, Kristin   (Chair)

Chan, Steven

Dick, John E

Keller, Gordon

Khokha, Rama

O'Brien, Catherine Adell

Schimmer, Aaron D

Tikhonova, Anastasia

Wang, Jean C.Y.

Kaufmann, Kerstin

Xie, Stephanie

Burke, Rafa Montenegro

Jones, Courtney

Lechman, Eric R

Tiedemann, Rodger

Jahangiri Tazehkand, Soheil

Iscove, Norman N

The main areas of research for the Supportive Care Program are Psychosocial Oncology, Palliative Care, and Cancer Survivorship and Rehabilitation. These areas overlap and include biopsychosocial, as well as neurocognitive effects of cancer and its treatment on patients and their families across the disease trajectory. These areas are investigated through longitudinal, intervention and implementation research to reduce suffering, optimize functioning and health, and improve quality of life throughout the course of illness.   

Zimmermann, Camilla (Chair)

Alibhai, Shabbir

Edelstein, Kim

Jones, Jennifer M

Li, Madeline

Rodin, Gary M

Bender, Jacqueline

Howell, Doris

Research Breakthroughs & Events

Pm research fact sheet, meet pm research.

View larger map

• Skip to main content
• Skip to "About this site"
• Departments

Language selection

• Search and menus

Institute of Cancer Research

Notice of Upcoming Funding Opportunity: Moving Upstream: Structural Determinants of Health Catalyst Grants (Structural Determinants of Cancer Inequities Pool)

TRANSCAN-3 Joint Transnational Call – Combination therapies against cancer

Congratulations to the Institute of Cancer Research Fall 2023 Project Grant Priority Announcement grantees!

Congratulations to the recipients of the 2023 Early Career Award in Cancer!

CIHR-ICR Research Priority Plan 2024-2029

The Institute of Cancer Research (ICR) funds cancer research in Canada based on internationally accepted standards of excellence, which bear on preventing and treating cancer, and improving the health and quality of life of cancer patients. CIHR is one of the leading cancer research funders in Canada.

Dr. Fei-Fei Liu

University Health Network

700 University Ave, 4th Floor, Room 4-099 Toronto, ON M5G 1Z5

27 phd-in-cancer-biology positions in Canada

Filtered by.

• phd-in-cancer-biology

Refine Your Search

• Research Job 12
• Scholarship 2
• Postdoctoral 8
• Fellowship 4
• Postgraduate 1
• University of Alberta 10
• McGill University 8
• University of British Columbia 6
• Faculty of Medicine, University of British Columbia 1
• Nature Careers 1
• Simon Fraser University, Faculty of Health Sciences 1
• Medical Sciences 8
• Chemistry 1
• Computer Science 1
• Economics 1

Research Associate - Bioinformatics, Cancer Proteomics & Personalized Medicine

training in bioinformatics, computational biology , cancer biology , proteomics or related area Strong statistical foundation and demonstrated strong expertise in R or python for data analysis Fluent in

Senior Scientist, Research

Domain expertise gained through a Bachelor’s or Master’s Degree with min.13 years of relevant experience; PhD with 9+ years of relevant experience (i.e., PhD in Cancer Genomics, Immuno Genomics, Oncology

Research Associate

: With a strong focus on interdisciplinary work, the position will involve working with researchers from diverse fields such as cell biology , cancer biology , biophysics, neuroscience and cellular

, departmental seminars, scientific conferences, and related settings Fosters communication with off-campus partners Works in BL2 biohazard containment Qualifications PhD in molecular and cellular biology

Post Doctoral Fellow in Biochemistry/Oncology

and collaborating with team members Minimum Qualifications PhD degree in Biochemistry, Cell Biology , or related discipline Extensive expertise in cell biology methods (cell culture and related

UBC President’s Excellence Chair in Precision Oncology

in cancer biology , genomics, proteomics, conventional and molecular imaging and bioinformatics. The successful candidate will have a MD, MD/ PhD , PhD or equivalent degree with specialty training in

Research Trainee- Master Program or PhD . Program (Research Institute)

discoveries through in depth analysis of tumor biology such as gene editing experiments Education / Experience Education: Bachelor's Degree Field of Study: Science Other education considered an asset

Postdoctoral Researcher - Imaging Scientist Advanced Bioimaging Facility (Dr. Brown's Laboratory)

courses and workshops. Keep up on the literature relevant to technologies in the facility and user projects. EDUCATION/EXPERIENCE Required PhD in preferred areas including Biophysics, Cell Biology , Cancer

, with dedicated research funding to support the successful candidate for the first seven years of the program, and access to exceptional platforms in cancer biology , genomics, proteomics, conventional and

Searches related to phd in cancer biology

• medical sciences
• cancer biology
• phd position cancer
• phd in biology
• phd in molecular biology

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals
• Explore content
• About the journal
• Publish with us
• Sign up for alerts
• 17 April 2024

Canadian science gets biggest boost to PhD and postdoc pay in 20 years

• Brian Owens

You can also search for this author in PubMed   Google Scholar

Researchers in Canada got most of what they were hoping for in the country’s 2024 federal budget, with a big boost in postgraduate pay and more funding for research and scientific infrastructure.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 51 print issues and online access

185,98 € per year

only 3,65 € per issue

Rent or buy this article

Prices vary by article type

Prices may be subject to local taxes which are calculated during checkout

Nature 629 , 19-20 (2024)

doi: https://doi.org/10.1038/d41586-024-01124-2

Reprints and permissions

Related Articles

• Scientific community

Who will make AlphaFold3 open source? Scientists race to crack AI model

News 23 MAY 24

Guidelines for academics aim to lessen ethical pitfalls in generative-AI use

Nature Index 22 MAY 24

Protests over Israel-Hamas war have torn US universities apart: what’s next?

News Explainer 22 MAY 24

US halts funding to controversial virus-hunting group: what researchers think

News 16 MAY 24

A DARPA-like agency could boost EU innovation — but cannot come at the expense of existing schemes

Editorial 14 MAY 24

Why the European Space Agency should join the US mission to Uranus

Comment 20 MAY 24

China's Yangtze fish-rescue plan is a failure, study says

News 20 MAY 24

Full Professorship (W3) in “Organic Environmental Geochemistry (f/m/d)

The Institute of Earth Sciences within the Faculty of Chemistry and Earth Sciences at Heidelberg University invites applications for a   FULL PROFE...

Heidelberg, Brandenburg (DE)

Universität Heidelberg

Postdoc: deep learning for super-resolution microscopy

The Ries lab is looking for a PostDoc with background in machine learning.

Vienna, Austria

University of Vienna

Postdoc: development of a novel MINFLUX microscope

The Ries lab is developing super-resolution microscopy methods for structural cell biology. In this project we will develop a fast, simple, and robust

Postdoctoral scholarship in Structural biology of neurodegeneration

A 2-year fellowship in multidisciplinary project combining molecular, structural and cell biology approaches to understand neurodegenerative disease

Umeå, Sweden

Umeå University

Group Leader (Microbes and Food Safety)

Full or Part Time We are looking for a dynamic, proactive individual to lead a research programme contributing to our goals of reducing foodborne i...

Norwich, Norfolk

Quadram Institute Bioscience

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies

• How It Works

As CGEn's leading executive, the CEO role is to drive CGEn's Strategic Vision and continue to shape CGEn as a high-performing, service-oriented organization that is driven by a culture of excellence and collaboration and will enable Canada's genomics research community to remain competitive on the national and international stage. The CEO will work with the Board of Directors and the Executive Committee to create and operationalize its strategic plan that will result in significant multi-year research infrastructure investment in CGEn.

SickKids Hospital CGEn

Toronto, ontario.

PhD, Senior Leadership

The Ministry of Public and Business Service Delivery's Operational Policy, Business Intelligence, and Strategic Planning unit is recruiting one highly motivated Senior Research Analyst to join the team that delivers, reviews, and assesses the data environment that supports the delivery of key consumer protection legislation. 

Ontario Public Service Careers

Toronto and remote, ontario.

Research Analyst

Canadian and Permanent Residents

Seeking a Senior Biomedical Scientist to    support Lunella Biotech’s mission in the discovery of anti-ageing and anti-cancer therapeutics.  This position will involve the screening and discovery of drugs that target the metabolic phenotype of senescent cells and cancer stem cells, across multiple cancer types.

Lunella Biotech

Ottawa, ontario.

Cancer Anti Aging

PhD Bio / Pharma sciences

Seeking a Principal Biomedical Scientist to support Lunella Biotech’s mission in the discovery of anti-ageing and anti-cancer therapeutics.

This position will involve the screening and discovery of drugs that target the metabolic phenotype of senescent cells and cancer stem cells, across multiple cancer types.

Cancer and Aging

PhD Bio sciences

Join an active and vibrant team enthusiastic about science and molecular imaging. The position is responsible for the maintenance and operations of state-of-the-art imaging equipment in the Archer research laboratory located in Botterell Hall. The key equipment the incumbent will be responsible for operating is a super-resolution confocal microscope with FLIM (Fluorescence Lifetime Imaging Microscopy) and STED (STImulated Emission Depletion) capabilities. The Archer lab is a CIHR and CFI funded laboratory that does research in numerous areas, the main focus is on mitochondrial biology and experimental therapeutics for pulmonary hypertension, cancer and cardiac ischemia-reperfusion injury. The incumbent will design and implements a research plan, develop experimental approaches and adapting techniques and protocols as required.

Dept. of Medicine Queen's University

Kingston, ontario.

Medical Research

Masters, PhD, Biology, Biochemistry, Physiology

Research Security is vital for the University of Windsor for both researchers and funding partners on an  international, national and provincial level. The Research Security Coordinator will oversee all research  project related risk analyses and project assessments. The incumbent will function as an interface with  members of the university research community, directors and external government and industry stakeholders with the goal of supporting a secure research environment. 

University of Windsor Office of Research Partnerships

Windsor, ontario.

Research Risk Management

Research Security and Policy

Inviting applications for a Postdoctoral Fellowship in Mass Spectrometry in the department of chemistry at Vancouver Island University . This two-year position is a key part of a multi-institutional project utilizing cutting-edge mass spectrometry imaging technology to explore molecular mechanisms of tumor driven immunosuppression in various types of solid cancers. The primary focus of this role is to develop and apply nanospray desorption electrospray ionization (nano-DESI) methods to map metabolites in heterogeneous tumors.

Vancouver Island University - Chemistry Department

Vancouver island, british columbia.

Mass Spectrometry for cancer research

Analytical Chem, Biological Science - Post Doc

The Robarts Research Institute within the Schulich School of Medicine & Dentistry at Western University seeks a Research Scientist to provide guidance and consultation related to a variety of research functions through the development of MRI experimental strategies.  The role will facilitate research by participating in the design and implementation and providing related guidance on equipment, as well as best approaches for project development, implementation, and evaluation.  The role will set research goals and objectives, carry out and oversee original and independent research, develop new research initiatives, prepare grant applications, and play a lead role in training and fostering relationships with collaborators, staff, graduate students, undergraduate students and post-doctoral fellows. The Research Scientist will also select and develop methods for data collection, publish and present findings, and develop new and innovative research approaches to achieve desired research outcomes.

Western University - job #31527

London, ontario.

MRI Imaging Research

MRI Research Scientists

McGill University is seeking an experienced leader with an outstanding record of scholarship and research to become its next Vice-Principal, Research and Innovation (VPRI).

Reporting to the Principal and Vice-Chancellor and working collaboratively within a multi-campus system, the VPRI is an integral member of the University’s Executive Team and strategically leads institutional research priorities and objectives in an effort to further advance McGill’s leadership position as a research-intensive institution of higher learning.

As the University’s internal and external advocate for research, the VPRI will provide strategic and inspired leadership for all aspects of research, innovation and creative activity at McGill, with a mission of maintaining the University’s standing as Canada’s pre-eminent research-intensive university and enhancing the University’s standing globally. 

McGill University

Montreal, quebec.

Multidisciplinary Innovation and Research

Vice Principal Research and Innovation

The INRS Énergie Matériaux Télécommunications Research Centre (EMT) is seeking to fill one new tenure-track professor position as part of the Joint Research Unit between INRS and University of Québec in Outaouais (UQO), with a strong potential for transferring knowledge and technology to users in the cybersecurity sector.

Join a staff of some 40 professor-researchers to undertake research and provide training (MSc, PhD, and postdoc) in various fields such as telecommunication systems, multimedia signal processing and analysis, artificial intelligence, ultrafast science and photonics, advanced materials, sustainable energy, environmental solutions, and nanobiotechnology. The selected candidate will be given the support to apply for a Tier 2 Canada Research Chair as well as for Canada Foundation for Innovation (CFI) infrastructure support – John R. Evans Leaders Fund – to establish his/her research lab.

The INRS-UQO Joint Research Unit in Cybersecurity

Gatineau - ottawa, quebec.

Cybersecurity Research

PhD - CS and related fields

SickKids is looking for a dynamic Director with clinical and/ or research experience who can support the transformation of Clinical Research Services (CRS). Reporting to the Associate Chief of Clinical Research, and working with research, clinical, and operational leaders across the enterprise, the Director will support day-to-day CRS operations while simultaneously providing strategic leadership to support the modernization of policies, procedures, workflows, information service technologies, and infrastructure that support the high quality, safe, ethical, efficient, and equitable delivery of clinical research at SickKids.

SickKids Hospital

Clinical research leader

Masters level degrees. 7+ years team leader

The Tabori lab and the International Replication Repair Deficiency Consortium is looking for a highly motivated Research Fellow with outstanding organizational, critical thinking, quantitative data analysis and scientific writing skills to join our highly collaborative, multidisciplinary team. 

The Research Fellow will work on an exciting new initiative in the field of preventive immune-oncology . Specifically, the project aims to develop a robust immunological and preclinical foundation for novel LNP based RNA cancer vaccines . 

Preventive immune-oncology

Centennial College is looking for a strategic and hands-on leader to lead a dynamic data analytics and research team . Reporting to the Associate Vice President, Institutional Effectiveness, the Director will provide senior strategic leadership in the management and coordination of the College’s data needs and institutional research activities to inform planning and decision-making. The Director will oversee the collection, analysis, organization and reporting of institutional and external data, and will develop key metrics and monitoring frameworks for quality assurance. 

Centennial College - Data Analytics and Research Office - DARO

Toronto / remote, ontario.

Data Analytics, EDI

Director, Data Analytics and Research. Msc

Centennial College is seeking a change leader to deliver and operationalize strategic EDI initiatives across the enterprise. A unique opportunity reporting to the Associate Vice-President EDI, the Manager Research and Strategic Initiatives will plan and implement complex college-wide projects including the Centennial EDI Institutional Capacity Building Journey, oversee program effectiveness analyses, and be the principal project liaison between the Centennial community and the AVP. Working collaboratively and interculturally with a diverse array of internal and external stakeholders, the incumbent will play a critical role in the college’s ability to meet its overall strategic and academic planning objectives.

Centennial College

EDI Education

Manager Research and Strategic Initiatives Equity Diversity Inclusion

CERA seeks a motivated and committed senior research professional with strong research, organizational, project management and strategic thinking skills. The successful candidate will lead complex, multi-stakeholder research initiatives in support of CERA’s comprehensive approach to advancing the right to housing through policy-relevant research, advocacy, community engagement and government relations. This role requires expertise in housing policy, an understanding of the right to adequate housing, demonstrated experience leading research projects on housing and the ability to employ a variety of research methods.

Remote - Canada Wide, Ontario

Data Research And Strategy

PhD, MSc. Senior Researchers

CERA seeks a motivated and committed data professional with strong analytical, organizational, and strategic thinking skills to join our team and help us in our ambitious goal of advancing the right to housing for all. In this role, your ability to juggle multiple responsibilities under tight timelines is essential. 

Remote & Canada Wide, Ontario

Mathematics, Statistics, Data Scientist

At the CGEn -  Canada's national platform for genome sequencing & analysis - the  Director, Programs & Partnerships will lead all CGEn activities focused on CGEn led programs and help build partnerships with national and international projects and organizations to enhance CGEn’s ability to support and impact the Canadian genomics eco-system. The position reports to the CGEn Chief Executive Officer and works closely with the CGEn’s Operational Management team.

SickKids - The Hospital For Sick Children

Toronto & remote, ontario.

Healthcare, medical, hospital, research

Director, Programs & Partnerships

Reporting to the Deputy Minister of National Defence as well as the Chief of the Defence Staff, among other areas of responsibility the Assistant Deputy Minister is accountable for: the strategic vision of the organization; promoting a culture of innovation; ensuring its eight research centres and laboratories across Canada are managed effectively; and, guiding people through ongoing change. 

Relevant du sous-ministre de la Défense nationale et du chef d’état-major de la Défense, entre autres domaines de responsabilité, le sous-ministre adjoint est responsable de la vision stratégique de l’organisation et de la promotion d’une culture d’innovation. Il doit aussi veiller à ce que ses huit centres et laboratoires de recherche du Canada soient gérés efficacement et guider les gens dans le cadre du changement continu.

Defence Research and Development Canada (DRDC) / Recherche et développement pour la défense Canada (RDDC)

Ottawa and remote / ottawa et éloigné, ontario.

Defence and Security / Défense et sécurité

Assistant Deputy Minister / Sous-ministre adjoint

Seeking a visionary cancer trialist for the position of Senior Investigator (SI) to be co-principal investigator of individual trials, and leader within the CCTG program and the CCTG scientific committees. Senior Investigators also have Faculty appointments at Queen’s University.

Join an internationally recognized group of cancer trial experts participating in scientific and policy decision-making of the CCTG, providing scientific and administrative leadership to the overall scientific strategy of the group, identifing new research opportunities, contributing to CCTG / trial activities within an inclusive, diverse, collaborative, and healthy work environment. 

Canadian Cancer Trials Group Cancer Research Institute,

Kingston or remote, ontario.

Senior Investigator (SI). Cancer Care

Reporting to the President, and as a member of the senior leadership team, among other areas, the VPR-P is accountable for the strategic oversight of the Scientific Institutes and serves in various capacities at key executive level governance committees. The VPR-P joins a senior leadership team consisting of the President, Executive Vice President and the Vice President Research – Learning Health Systems Research in the development of science initiatives, strategies, and policies. The incumbent also works closely with the Scientific Directors of CIHR’s 13 Institutes, and plays a key role in helping to guide the implementation of the Strategic Plan and accompanying Annual Action Plans .

Cross Canada, Ontario

Research Health Science , Health Research Policy

Vice President Research

The Centre for Advanced Computing at Queen’s University is seeking an experienced leader to join our multi-faceted team as Director, Advanced Research Computing. Reporting to the Associate Vice Principal (Research), this individual will have a comprehensive understanding of the Advanced Research Computing (ARC) landscape on a regional and national level, and have experience working in a research environment with secure high-performance computing and storage systems. The Director, Advanced Research Computing will be responsible for managing a dynamic team through multi-functional projects, requiring the incumbent to possess exceptional change management knowledge and ability to apply to diverse situations.

Queen's University

Field: Computer Science

Position: Director Advanced Computing

This is an exciting opportunity for an experienced researcher whose advanced skills in qualitative and quantitative research are coupled with expert knowledge of equity, anti-oppression and anti-racism frameworks, to support evidence-informed decision-making and transformative systemic change across the Peel District School Board (PDSB).

Peel District School Board

Peel region, ontario.

Education and Policy

Research Officer

The Pacific Institute for Climate Solutions (PICS) Researcher-in-Residence position offers an exceptional opportunity to be at the nexus of climate solutions research and engagement focusing on the impact of sea level rise on coastal communities and the development of integrated flood adaptation strategies and design solutions.

Pacific Institute for Climate Solutions (PICS)

Victoria, british columbia.

Coastal Management, Climate Solutions

Researcher in residence

The Health Sector Information, Analysis and Reporting Division (HSIAR) sets the foundation for the delivery of high-quality health sector information, analytics and reporting. The Division leads key information management functions including data stewardship, governance, security, access, analytics and reporting, quality assurance, performance measurement and evaluations functions. HSIAR sets out to exercise effective governance over secondary use data resources, while enabling timely and secure access to data, supporting an integrated, modernized model of information sharing across the health sector. The Division leads the overarching provincial analytic strategy and approach, and performs comprehensive, robust and integrated analytics, research and evaluation of health sector performance. To ensure a consistent and timely approach to health system evaluation and continuous improvement, the Division is responsible for the development of the overarching policy framework and monitoring of outcomes and impacts of health system policy direction.

The  Director Methodologies and Cross Sector  is responsible for leading, directing and providing oversight for the development and implementation of methodologies that apply to statistics, methodologies and classifications. In the Director role, you will oversee the production of reports analyzing methodology and integration of analysis in planning documents from across the health sector that inform decision making. 

BC Public Service

Health Services

One (1) Director

Waypoint Centre for Mental Health Care is a University of Toronto teaching hospital and academic research centre located on the shores of Georgian Bay in the town of Penetanguishene, only 45 minutes from Barrie and 90 minutes from Toronto.

A Post-Doctoral Fellowship is available under the supervision of Dr. Nathan Kolla, Vice President, Research & Academics, and in association with the Department of Psychiatry, University of Toronto. This Fellowship offers the opportunity to gain and contribute knowledge to the area of risk factors and assessment . The ideal student is interested in forensic mental health, psychopathy, genetics, neuroscience and risk factor identification.

Waypoint Research Institute

Evidence-Based Mental Health and Addictions Research

One (1) post-doctoral fellowship

VIU invites applications for a Tier 2 Canada Research Chair in the area of  Community-based Kinesiology and Physical Literacy . Tier 2 Canada Research Chairs are exceptional, emerging researchers acknowledged by their peers as having the potential to demonstrate world-class leadership. VIU’s Sport, Health and Physical Education (SHAPE) Program offers a Bachelor of Arts, Minor/Major degree in Physical Education. The department is searching for a dynamic faculty member early in their career who has demonstrated research and leadership in the area of community-based kinesiology, physical literacy, health and wellness. Additionally, the candidate should be committed to teaching excellence with a strong interest in student engagement and success.  Collegiality, flexibility, and enthusiasm/passion for the art and science of movement   are important characteristics outlined in the SHAPE Vision.

The CRC will have 75% of their position dedicated to research and 25% towards teaching (equivalent to two courses annually). The teaching responsibilities will be determined based on the disciplinary and teaching background of the candidate. The CRC will become a faculty member in the Faculty of Education. Canada Research Chairs are tenable for five years and renewable once, after which time, the CRC will become a full-time faculty member. The CRC will be provided with an operating grant for their research program and may apply for Canada Foundation for Innovation funding.

Vancouver Island University

Nanaimo, british columbia.

Kinesiology, Physical Literacy, Physical Education,

One (1) Tier 2 Canada Research Chair

Vancouver Island University invites applications for a Tier 2 Canada Research Chair in the area of  Indigenous Education  with a focus in teaching and learning.  Tier 2 Chairs are for exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field. This CRC will aid VIU in achieving the  Teaching and Learning  and the  Equity, Diversity and Social Justice  foci of the Strategic Research Plan.

The Faculty of Education at VIU offers BEd, post-baccalaureate and Master’s of Education programs for undergraduate and graduate students. We are seeking a candidate whose expertise is in the area of Educational Research, Indigenous Knowledge, curriculum development, or action research applied in education/learning contexts to support our Faculty’s  Vision .  Candidates will bring expertise in Aboriginal education or culturally responsive teaching.  

The CRC will have 75% of their position dedicated to research and 25% towards teaching (equivalent to 2 courses annually). The teaching responsibilities will be determined based on the disciplinary and teaching background of the candidate. The CRC will become a faculty member in the Faculty of Education. In addition to the faculty of Education, candidates will be invited to participate in related programming at VIU such as Studies in Women and Gender or our Indigenous/Xwulmuxw Department. Research Chairs are tenable for 5 years and renewable once, after which time, the CRC will become a full-time faculty member. The CRC will be provided with an operating grant for their research program and may apply for Canada Foundation for Innovation (CFI) funding. 

Indigenous Education, Equity, Diversity, Social Justice, Teaching, Research

Vancouver Island University invites applicants for a Tier 2 Canada Research Chair in  Human Dimensions of Sustainability and Resilience . Tier 2 Chairs are for exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field. This CRC will aid VIU in achieving the Health, Resilience and Well-being and Resilient Island and Rural Regions foci of the Strategic Research Plan.

Sustainability is a core value at Vancouver Island University. An inherently interdisciplinary topic of study, it also enables the convergence and collaboration of faculty in a number of disciplines. This Canada Research Chair will develop a highly interdisciplinary program of research that brings together the insights from disciplines in the social sciences such as sociology, psychology, geography, and leisure management to understand the human dimensions of environmental sustainability and community resilience. Through collaborative interdisciplinary and transdisciplinary work, this CRC will contribute greater insights on how human knowledge, actions, processes and interactions are influenced and informed by natural and cultural systems and places. Potential areas of study may include, but are not limited to, interactions of humans and natural/cultural environments, environmental psychology, conservation, sustainable design and development, community and regional resilience and social innovation.

The Waypoint Research Institute is currently seeking a full time Research Scientist with specialization in epidemiology and/or bio-statistics. The purpose of this position is to lead or assist with major research projects; provide high level expertise and advice regarding the use of a broad range of advanced statistical analysis techniques, complex database development and maintenance (including electronic health records), and the development and implementation of a range of sophisticated research methodologies and approaches to Principle Investigators and other researchers at the Institute; provide advice and recommendations on appropriate research strategies and interpretation of results to the Research Teams, Director, Research & Academics and the Vice President, Research & Academics, and external collaborators.

Position Title: Research Scientist – Epidemiology/Bio-Statistics

Job Class:   Research Scientist 1

Dept/Program:   Research & Academics                                    

Rate of Pay:  $47.18 - $56.33 per hour

Employment Type: Full Time                                                   

Employee Group:   OPSEU

Work Schedule: 37.50 hours weekly as per schedule                

Sarah Jorgensen, Waypoint Research Institute

Research & Academics - Epidemiology & Biostatistics, Mental Health

One Full-Time Position

Normal 0 false false false EN-CA X-NONE X-NONE

Position Title: Post-Doctoral Fellow

Dept/Program:  Research & Academics                              

Employment Type: Temporary Full Time up to 2 years     

Employee Group:  Non-Union

Work Schedule: 37.50 hours weekly as per schedule        

Posting Date: January 4th, 2019

Posting Type:  Open                                                            

Number:  1

Shift Type:  Days

Job Class:  Under Review 

Rate of Pay:  Under Review

As the Biostatistician/Statistician Advisor, you will support the efforts of the Regional Health Management Team (RHMT) in improving their knowledge of statistics so that they can better analyze and create methods of interpreting the vast amounts of medical data that they have. You will also help them to better assess the risks and benefits of various medical procedures in their catchment area. A large part of your day to day work will involve designing new and insightful studies, collecting the relevant information from physicians and patients, and compiling these raw numbers into a sensible form. By evaluating the risk factors present in Kigoma population, you will be able to compute the dangers of and solutions to the spread of disease.

Regional Health Management Team-Kigoma/CUSO INTERNATIONAL

Kigoma, tanzania.

Bioinformatics

One Biostatistician/Statistician Advisor for 12 months

The two open Postdoctoral Research Fellows positions at the Institut du Savoir Montfort (ISM)- Research located in Ottawa, Ontario, Canada shall contribute to the Research & Development for the new Center of Clinical Excellence in Multimorbidity of the Montfort Hospital.

Under the supervision of the team leader, Alain Mouttham, PhD, the research will investigate leading edge Artificial Intelligence and Deep Machine Learning approaches to clinical decision support systems, in the context of care to patients with Multimorbidity. Research will be followed by Development of prototypes of such clinical decision support systems which will be validated in pilot projects undertaken jointly with the hospital clinicians and health professionals.

Institut du Savoir Montfort

Clinical decision support systems for multimorbidity. Computer Science. Health Informatics

Two Postdoctoral Research Fellow Positions.

PolicyWise for Children & Families (PolicyWise) is recruiting a Research Director, Data Initiatives.

PolicyWise exists to improve child, family and community well-being through leading, creating and mobilizing research and evaluation for evidence-informed policy and practice. 

PolicyWise for Children & Families

Edmonton, alberta.

Policy development and analysis

Research Director

96 800x600 Normal 0 false false false EN-US X-NONE X-NONE

Are you a driven research professional looking to showcase your technical and people management skills? Then consider this unique opportunity with the Ministry of Municipal Affairs and Housing, Housing Policy Branch!

Ministry of Municipal Affairs and Housing

Housing Policy

The Executive Director works to foster collaboration among research funding agencies to successfully implement CCRA’s Pan-Canadian Cancer Research Strategy Target 2020: A Strategy for Collaborative Action, 2015-2020 leads the Partnership’s role in fostering alignment with relevant aspects of the CCRA’s strategy.

You will be reporting through the Cancer Control Division for operational accountabilities, and to the CCRA Board for establishing and executing strategic priorities and for ensuring the effective functioning of CCRA.

Canadian Cancer Research Alliance (CCRA)

Cancer Research, Strategy and Policy

Reporting to the Principal Investigator within the Faculty of Engineering, you will plan and execute non-routine assignments of varying complexity requiring deep knowledge of related engineering or scientific theory, principles and practices. More specifically, as a Research Associate – Engineer, you will work in a lab setting on the development of prototypes in preparation for demonstrations. The working language is English. This is a contract position of approximately 12 months, with possible renewal.

University of Ottawa

Engineering

Research Associate

A postdoctoral research position is immediately available at the Mining Innovation, Rehabilitation and Applied Research Corporation (MIRARCO) to undertake research on geomechanics issues related to mining at great depth.   The successful applicant will work under the supervision of Drs Peter K. Kaiser and Ming Cai at Laurentian University and will also be expected to train and mentor junior researchers and graduate students, write research reports and publications and assist in the preparation of research proposals. At this stage, the research may be related to the interpretation of monitoring data from pillar load testing, rock bursting and the determination of strainburst potential, and the collection of data in underground environments. For these reasons, applicants must demonstrate experience with underground work (tunnelling or mining), numerical modelling, and instrumentation as well as practical interpretation of field observations. 

Sudbury, Ontario

Geomechanics

Postdoctoral Researcher in Geomechanics

Improving the quality of Ontario’s health care system is a critical goal at HQO. If you are committed to improving overall health system performance, this position offers an ideal opportunity to support this transformational mandate. HQO is the provincial advisor on quality, a catalyst for quality improvement, an independent source of information on health evidence and a trusted resource for monitoring the performance of the Province's publicly funded health system.

Health Quality Ontario

Health System Performance

Vice President, Health System Performance

Reporting to the VP, Cancer Control, the Director provides program leadership for the project’s national coordinating centre and, working collaboratively with the project’s Senior Scientific Leader, provides input into the strategic leadership and general oversight of this key project.

The Director is a member of the Partnership’s Strategic Management Committee that includes the CEO, Vice Presidents and Directors, and will contribute to the organization’s strategic decision making to achieve its mandate in cancer control.

Canadian Partnership Against Cancer

Cancer Research

Reporting to the Associate Dean, Research and Graduate Studies, this position is responsible for enhancing and promoting the Lassonde School of Engineering (LSE) as a centre of excellence in research The incumbent serves as an advisor to the Associate Dean, Research and Graduate Studies and the Dean regarding: the overarching strategic direction for research; development, and implementation of research policy; identification and development of research partnerships with government, industry and community; coordination of major research initiatives; stimulation of nominations for awards; promotion of Faculty-research initiatives; and building research capacity within the faculty through communication, education, and training. Additionally, the incumbent serves as advisor to the Dean, Associate Dean and Department Chairs regarding the strategic direction of graduate studies within LSE: develops, implements and oversees the effective delivery of the graduate studies program.

York University

Research Partnerships Director

PhD preferred, 5+ experience in academic research

The mission for the Vice President, Research and Innovation is to reduce system burden to support a more sustainable health system and yield high impact results across the Hospital’s three sites.

Priorities include Development of New Models of Care, Operational Modeling, Health Information Technology, Awareness Projects and Research and Integration of Health Practice with Curriculum. With a number of the research team already in place, you’ll have the opportunity to quickly plan and evolve Trillium’s research capacity and translate it into applied innovation on behalf of its patients.

We seek an outstanding senior research leader committed to system performance and innovation, you are also an exceptional relationship developer capable of inspiring teams, peers and stakeholders with your vision of possibilities. You won’t find an organization more open to the possibilities than Trillium Health Partners.

Trillium Health Partners

Health Research and Healthcare

Vice President, Research and Innovation

Normal.dotm 0 0 1 60 342 Microsoft Office Suite 2 1 420 12.0 0 false 18 pt 18 pt 0 0 false false false

The  Vice President for Science at  Compute Canada - Calcul Canada,  will develop a national strategy  to promote and support the shared use of advanced computing to enables research and innovation for Canada.  

The role will report to the CEO and Research Advisory Committee, and advocate for research and innovation both within the organization and nationally. As an active researcher, you will have the opportunity to continue to be based out of your home university, but with frequent travel to meet with your colleagues at Compute Canada and others across the country.  

Compute Canada - Calcul Canada

Vancouver, british columbia.

Computer science

Vice President, Science

The inaugural Leslie Diamond Chair in Cancer Survivorship will enhance the development, execution and translation of cancer survivorship research at regional, national and international levels. Focusing upon the phase of the cancer trajectory occurring after primary treatment, including the challenges of effective transitioning to palliative and end of life care, the new Chair will conduct research to address the  needs of cancer survivors and their families in the context of health system innovation.

Simon Fraser University (SFU) and the British Columbia Cancer Agency (BCCA)

Leslie Diamond Chair in Cancer Survivorship

As the visionary leader of the Foundation, the President and Chief Executive Officer is responsible for developing and directing strategic and innovative programs which promote research excellence and generate benefits for the health and health care of British Columbians. Promoting collaboration among organizations and across multiple jurisdictions, the incumbent works with government, institutions and researchers to advance health research and address health and health system priorities.

Michael Smith Foundation for Health Research

President and CEO

Successful senior executives with a record of achievement in Health Research

The Planetary Exploration group is looking for two Post Doctoral fellows to work on various aspects of the Alpha-Particle X-ray Spectrometer (APXS). The APXS is an in-situ x-ray spectrometer for elemental analysis with a long history of successful deployments on Mars Pathfinder and the Mars Exploration Rover missions. An improved APXS will be launched on the Mars Science Laboratory (MSL) end of 2011.

Department of Physics, University of Guelph

Guelph, ontario.

Physics: Applied

Copyright Canadian Research 2022

• how it works

Fumiya Inaba receives CIHR Canada Graduate Scholarships - Master's Award

Congratulations to Fumiya Inaba (Integrative Oncology), for receiving a Canada Graduate Scholarships - Master's Award (CGS-M) from the Canadian Institutes of Health Research (CIHR).

The award is tied to a project titled, "Deep Learning Nuclei Segmentation to Predict Risk Groups in Prostate Cancer.”

The CIHR CGS-M awards provide special recognition and financial support to students who are pursuing a Master's degree in a health-related field in Canada, and are expected to have an exceptionally high potential for future research achievement and productivity.

Please join us in congratulating Fumiya on this achievement!

BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.

Donate Today

BC Cancer Research

• Strategic Plan
• BBRS Services
• Access Biospecimens & Data
• Application Process
• Biospecimens - Types & Services Available
• Fees, Timelines, Quality & Clinical Data
• Registration & Certification
• Informed & Voluntary Consent
• Research Supported
• News & Publications
• Contact BBRS
• News and Events
• Students & Trainees

Office of Research Administration

• News & Events
• Students & Trainees

Cancer Control Research

Genome sciences centre, terry fox laboratory, molecular oncology, integrative oncology, lymphoid cancer research, experimental therapeutics, clinical research, deeley research centre.

• Nursing and Allied Health Research and Knowledge Translation
• BC Cancer Foundation

Cancer Tissue and Pathology

The Cancer Tissue and Pathology Shared Resource facilitates discovery by providing high-quality human cancer specimens and comprehensive histopathologic services to cancer researchers.

• Request Service via PPMS

The Cancer Tissue and Pathology Shared Resource is intended and designed to help both individual and team science projects across all major and developing programs within Winship Cancer Institute of Emory University.

The shared resource provides two main resources to support basic, clinical and translational research: high-quality human cancer tissues and histopathologic services.

Tissue Biobanking Services

The tissue biobank works with all major disease groups at Winship Cancer Institute to collect, store and distribute tumor and normal control tissues for research. Biospecimens are collected under a central IRB-approved biobank protocol or other disease-specific or specialized protocols. Biospecimens are procured as frozen, fresh, fixed, embedded or other specialized preparation. Tissues and biospecimens are stored or distributed to Winship investigators with IRB-approved protocols to further clinical, translational, basic and epidemiologic research. Quality assurance of specimens is provided by members of the Department of Pathology.

The lab is capable of processing high volumes of tissue samples derived from remnant surgical tissue samples and works in close collaboration with members of each of the main and developing scientific programs of the Winship. The tissue biobank consists of an IRB-approved Human Tissue Procurement Service (HTPS), located within Emory University Hospital and Winship Cancer Institute, with affiliated banking sites at Grady Memorial and Emory University Midtown Hospital.

Histopathologic Tissue Services

Conveniently located in Winship's Shared Resource Hub on the 3rd floor of The Emory Clinic Building B, the Cancer Tissue Pathology Lab offers comprehensive histopathologic services ranging from tissue embedding and cutting to multiplex IHC. The laboratory can provide for nearly all tissue-based needs of investigators.

It is equipped with the following:

• Automated tissue processor
• Embedding station
• Three microtomes and water baths
• Automated slide labeler
• Automated stainer and coverslipper
• Automated single and multiplex immunohistochemical stainer
• Manual tissue microarrayer
• Semi-automated microarrayer

Our lab facility is located in the Winship Shared Resources Hub on the 3rd floor of The Emory Clinic Building B.

For digital pathology, the lab provides:

• Olympus Nanozoomer whole-slide scanner
• Vectra Polaris multispectral imaging system

Additional equipment includes:

• A fume hood for manual histologic staining of cryostat sections or benchtop IHC staining.
• A two-headed microscope with digital camera and imaging software for image capturing.

Publication Acknowledgement Policy

The National Cancer Institute requires that publications acknowledge the Winship Cancer Institute Cancer Center Support Grant (CCSG), and it is tracking compliance. If a Winship Cancer Institute CCSG-supported Shared Resource provided data, designed the study, performed analyses, provided results used in your publication, and/or provided any systems or services that were used for the work that resulted in your publication, please include the following statement in the acknowledgment section of your publication(s):

Research reported in this publication was supported in part by the Cancer Tissue and Pathology Shared Resource of Winship Cancer Institute of Emory University and NIH/NCI under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Core Leaders

Brian s. robinson, md, phd scientific director, cancer tissue and pathology shared resource.

Winship Cancer Institute of Emory University

A gastrointestinal pathologist, Dr. Robinson's clinical focus is in gastrointestinal and hepatic pathology.

• View Profile

Jennifer M. Robertson, PhD Core Director, Cancer Tissue and Pathology Shared Resource

Dr. Robertson serves as core director of the Cancer Tissue and Pathology Shared Resource and as director of research projects at Winship Cancer Institute of Emory University.